Literature DB >> 25069637

Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis.

Nanzheng Chen1, Qianqian Geng2, Jianbao Zheng1, Sai He1, Xiongwei Huo1, Xuejun Sun1.   

Abstract

The hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis have rarely been discussed and its mechanisms of action in alcohol-induced liver disease remain unknown. In this study, serum alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were measured to assess hepatic function; histopathological and immunohistochemical observations were used to evaluate pathological and specific molecular changes in liver tissue and flow cytometry was used to detect the apoptosis in cultured hepatic stellate cells (HSCs), the major fibrogenic cells in the liver; PCR and western blot analysis were employed to evaluate the changes in the expression of molecules and signaling pathways. We demonstrate that curcumin alleviates alcohol-induced hepatic fibrosis by affecting the HSCs. We found that the administration of curcumin inhibited alcohol-induced HSC proliferation and even induced HSC apoptosis by stimulating endoplasmic reticulum (ER) stress. We also found that by suppressing the transforming growth factor-β (TGF-β)/Smad signaling pathway, the administration of curcumin impaired the production of extracellular matrix proteins in alcohol-stimulated HSCs. These results indicate that curcumin exerts its hepatoprotective effects against alcohol-induced hepatic fibrosis by inhibiting the proliferation and inducing the apoptosis of HSCs by stimulating ER stress and deactivating HSCs by suppressing the TGF-β/Smad signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25069637     DOI: 10.3892/ijmm.2014.1867

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  12 in total

Review 1.  Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

Authors:  Alex Boye; Yu-Hong Zou; Yan Yang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.

Authors:  Yong-Zhan Zhen; Na-Ren Li; Hong-Wei He; Shuang-Shuang Zhao; Guang-Ling Zhang; Xiao-Fang Hao; Rong-Guang Shao
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 3.  Food components with antifibrotic activity and implications in prevention of liver disease.

Authors:  Minkyung Bae; Young-Ki Park; Ji-Young Lee
Journal:  J Nutr Biochem       Date:  2017-11-16       Impact factor: 6.048

4.  The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.

Authors:  Chao Yan; Lin Wang; Bo Li; Bei-Bei Zhang; Bo Zhang; Yan-Hong Wang; Xiang-Yang Li; Jia-Xu Chen; Ren-Xian Tang; Kui-Yang Zheng
Journal:  Parasit Vectors       Date:  2015-02-04       Impact factor: 3.876

5.  Emodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contact.

Authors:  Tian Yang; Jinyuan Wang; Yamei Pang; Xiaomin Dang; Hui Ren; Ya Liu; Mingwei Chen; Dong Shang
Journal:  Mol Med Rep       Date:  2016-10-12       Impact factor: 2.952

Review 6.  Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.

Authors:  Chenxia Hu; Lingfei Zhao; Jinfeng Duan; Lanjuan Li
Journal:  J Cell Mol Med       Date:  2019-01-11       Impact factor: 5.310

Review 7.  The Natural Occurring Compounds Targeting Endoplasmic Reticulum Stress.

Authors:  Hai Liu; Jianqiong Yang; Linfu Li; Weimei Shi; Xiaoliang Yuan; Longhuo Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-03       Impact factor: 2.629

Review 8.  Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives.

Authors:  Xiao-Yu Xu; Xiao Meng; Sha Li; Ren-You Gan; Ya Li; Hua-Bin Li
Journal:  Nutrients       Date:  2018-10-19       Impact factor: 5.717

9.  Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis.

Authors:  Ji Wang; Wen Pan; Ying Wang; Wan Lei; Bin Feng; Caigan Du; Xiao-Juan Wang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  Reconstruction and analysis of competitive endogenous RNA network reveals regulatory role of long non‑coding RNAs in hepatic fibrosis.

Authors:  Hui Jiang; Furong Wu; Nannan Jiang; Jiarong Gao; Jiafu Zhang
Journal:  Mol Med Rep       Date:  2019-09-13       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.